Dr. Martin J. Schear

Family Medicine
1100 Salem Ave, 
Dayton, OH 
Accepting New Patients
1100 Salem Ave, 
Dayton, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Martin Schear is a primary care provider, practicing in Family Medicine in Dayton, Ohio. Dr. Schear is rated as an Experienced provider by MediFind in the treatment of Axillary Nerve Dysfunction. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Sciatica. Dr. Schear is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in OH
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1100 Salem Ave, Dayton, OH 45406

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Biological
Study Phase: Phase 2
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Biological
Study Phase: Phase 3
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
View 6 Less Clinical Trials

1 Total Publications

Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Journal: The Pediatric infectious disease journal
Published: May 25, 2012
Similar Doctors
Advanced in Axillary Nerve Dysfunction
Dr. John M. Thuney
Family Medicine
Advanced in Axillary Nerve Dysfunction
Dr. John M. Thuney
Family Medicine

Alliance Physicians Inc

50 N Progress Dr, 
Xenia, OH 
 (14.8 miles away)
937-562-2280
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Thuney is a primary care provider, practicing in Family Medicine in Xenia, Ohio. Dr. Thuney is rated as a Distinguished provider by MediFind in the treatment of Axillary Nerve Dysfunction. His top areas of expertise are Xanthoma, Familial Combined Hyperlipidemia, Cirrhosis, and High Cholesterol. Dr. Thuney is currently accepting new patients.

Advanced in Axillary Nerve Dysfunction
Dr. Derek W. Thomson
Family Medicine
Advanced in Axillary Nerve Dysfunction
Dr. Derek W. Thomson
Family Medicine

Thomson Medical LLC

79 W Central Ave, 
Camden, OH 
 (25.1 miles away)
937-452-1201
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Derek Thomson is a primary care provider, practicing in Family Medicine in Camden, Ohio. Dr. Thomson is rated as an Experienced provider by MediFind in the treatment of Axillary Nerve Dysfunction. His top areas of expertise are Empyema, Sinusitis, Axillary Nerve Dysfunction, and Down Syndrome. Dr. Thomson is currently accepting new patients.

Experienced in Axillary Nerve Dysfunction
Dr. Gary P. Erdy
Family Medicine
Experienced in Axillary Nerve Dysfunction
Dr. Gary P. Erdy
Family Medicine
214 Elm St, 
London, OH 
 (41.8 miles away)
740-845-4100
Languages Spoken:
English
See accepted insurances

Gary Erdy is a primary care provider, practicing in Family Medicine in London, Ohio. Dr. Erdy is rated as an Advanced provider by MediFind in the treatment of Axillary Nerve Dysfunction. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Axillary Nerve Dysfunction, and Vascular Dementia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schear's expertise for a condition
ConditionClose
        View All 28 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile